Staging and assessment of lymph node involvement by 18F-fluorodeoxyglucose-positron emission tomography in invasive extramammary Paget's disease.
BACKGROUND
18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a functional and metabolic imaging modality that is efficacious in nodal staging and detection of extranodal involvement for malignant tumors.


OBJECTIVE
We describe the novel use of PET for staging patients with invasive extramammary Paget's disease (EMPD) and discuss the potential advantages of this technology relative to other diagnostic modalities.


METHODS
We evaluated three patients with invasive EMPD whose staging was made by PET at Hokkaido University Hospital.


RESULTS
All lymph nodes detected by PET were over 10 mm. Distant internal metastases were not seen in all cases. PET failed to detect 10 and 5 to 7 mm nodal involvement but succeeded in detecting nodes over 10 mm.


CONCLUSIONS
These data suggest that PET may be useful in determining disease activity at the time of initial diagnosis but is less useful and proves difficult to detect a small or subclinical involvement. This is the first report of PET being used for invasive EMPD.
Aoyagi
Satoru
S
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. aoyagi.ms@mac.com
Sato-Matsumura
Kazuko C
KC
Shimizu
Hiroshi
H
D000368:Aged; D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D005834:Genital Neoplasms, Male / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D010145:Paget Disease, Extramammary / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18